Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and ten have assigned a […]
More Stories
Washington Monument Illumination Kicks Off Yearlong Celebration of America’s 250th Birthday
By Jeff Louderback On the campaign trail in his bid for a White House return, President Donald Trump pledged to...
Trump Vows to Intervene if Iran Kills Protestors
By Guy Birchall President Donald Trump on Jan. 2 vowed to come to the aid of protesters in Iran if...
Emily in Paris Season 6: Netflix Renewal Status and Expectations
Emily in Paris is a story of a 29-year-old girl who has shifted from Chicago to Paris for a job...
Kate Winslet’s Net Worth in 2026: Assets, Salary, and Relationships
With a huge net worth, Kate Winslet has been enjoying a fantastic career that has seen her successfully combine blockbusters...
NIL (Name, Image, and Likeness): Top 20 Highest-Paid College Athletes
The NCAA (National Collegiate Athletic Association) is a US-based government body that regulates the rules of sports in colleges and...
Porsche Recalls More than 173,500 Vehicles for Rear-Camera Malfunction
By Rob Sabo Porsche Cars North America, Inc. has issued a recall of 173,538 vehicles manufactured during the past six...